Mehendale HM - Search Results

1

Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity.

Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM. Donthamsetty S, et al. Among authors: mehendale hm. Hepatology. 2007 Feb;45(2):391-403. doi: 10.1002/hep.21530. Hepatology. 2007. PMID: 17256749

2

Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats.

Sawant SP, Dnyanmote AV, Shankar K, Limaye PB, Latendresse JR, Mehendale HM. Sawant SP, et al. Among authors: mehendale hm. J Pharmacol Exp Ther. 2004 Feb;308(2):694-704. doi: 10.1124/jpet.103.058834. Epub 2003 Nov 10. J Pharmacol Exp Ther. 2004. PMID: 14610242

3

Tolerance of aged Fischer 344 rats against chlordecone-amplified carbon tetrachloride toxicity.

Murali B, Korrapati MC, Warbritton A, Latendresse JR, Mehendale HM. Murali B, et al. Among authors: mehendale hm. Mech Ageing Dev. 2004 Jun;125(6):421-35. doi: 10.1016/j.mad.2004.03.005. Mech Ageing Dev. 2004. PMID: 15178132

4

Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.

Sawant SP, Dnyanmote AV, Warbritton A, Latendresse JR, Mehendale HM. Sawant SP, et al. Among authors: mehendale hm. Toxicol Appl Pharmacol. 2006 Mar 15;211(3):221-32. doi: 10.1016/j.taap.2005.07.019. Epub 2005 Sep 8. Toxicol Appl Pharmacol. 2006. PMID: 16153671

5

Upregulation of calpastatin in regenerating and developing rat liver: role in resistance against hepatotoxicity.

Limaye PB, Bhave VS, Palkar PS, Apte UM, Sawant SP, Yu S, Latendresse JR, Reddy JK, Mehendale HM. Limaye PB, et al. Among authors: mehendale hm. Hepatology. 2006 Aug;44(2):379-88. doi: 10.1002/hep.21250. Hepatology. 2006. PMID: 16871587

6

Prior administration of a low dose of thioacetamide protects type 1 diabetic rats from subsequent administration of lethal dose of thioacetamide.

Devi SS, Philip BK, Warbritton A, Latendresse JR, Mehendale HM. Devi SS, et al. Among authors: mehendale hm. Toxicology. 2006 Sep 21;226(2-3):107-17. doi: 10.1016/j.tox.2006.06.007. Epub 2006 Jun 16. Toxicology. 2006. PMID: 16901604

7

Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.

Mitra MS, Donthamsetty S, White B, Latendresse JR, Mehendale HM. Mitra MS, et al. Among authors: mehendale hm. Toxicol Appl Pharmacol. 2007 Nov 15;225(1):90-101. doi: 10.1016/j.taap.2007.07.018. Epub 2007 Aug 21. Toxicol Appl Pharmacol. 2007. PMID: 17904602

8

Secretory phospholipase A2 mediates progression of acute liver injury in the absence of sufficient cyclooxygenase-2.

Bhave VS, Donthamsetty S, Latendresse JR, Muskhelishvili L, Mehendale HM. Bhave VS, et al. Among authors: mehendale hm. Toxicol Appl Pharmacol. 2008 Apr 15;228(2):225-38. doi: 10.1016/j.taap.2007.12.023. Epub 2008 Jan 3. Toxicol Appl Pharmacol. 2008. PMID: 18329682

9

Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury.

Bhave VS, Donthamsetty S, Latendresse JR, Mehendale HM. Bhave VS, et al. Among authors: mehendale hm. Toxicol Appl Pharmacol. 2008 Apr 15;228(2):239-46. doi: 10.1016/j.taap.2007.12.025. Epub 2008 Jan 4. Toxicol Appl Pharmacol. 2008. PMID: 18336855

10

Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate.

Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM. Donthamsetty S, et al. Among authors: mehendale hm. Toxicol Appl Pharmacol. 2008 Aug 1;230(3):327-37. doi: 10.1016/j.taap.2008.02.031. Epub 2008 Mar 20. Toxicol Appl Pharmacol. 2008. PMID: 18501395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

268 results

Search Page